These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension. Abid S, Marcos E, Parpaleix A, Amsellem V, Breau M, Houssaini A, Vienney N, Lefevre M, Derumeaux G, Evans S, Hubeau C, Delcroix M, Quarck R, Adnot S, Lipskaia L. Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454 [Abstract] [Full Text] [Related]
23. Xbp1s-Ddit3 promotes MCT-induced pulmonary hypertension. Jiang H, Ding D, He Y, Li X, Xu Y, Liu X. Clin Sci (Lond); 2021 Nov 12; 135(21):2467-2481. PubMed ID: 34676402 [Abstract] [Full Text] [Related]
24. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway. Gao W, Shao R, Zhang X, Liu D, Liu Y, Fa X. Exp Cell Res; 2017 Dec 01; 361(1):192-198. PubMed ID: 29069575 [Abstract] [Full Text] [Related]
27. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C, Provencher S, Bonnet S. Respir Res; 2011 Sep 27; 12(1):128. PubMed ID: 21951574 [Abstract] [Full Text] [Related]
28. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin. Kinoshita D, Shishido T, Takahashi T, Yokoyama M, Sugai T, Watanabe K, Tamura H, Nishiyama S, Takahashi H, Arimoto T, Miyamoto T, Watanabe T, Kishida S, Kadomatsu K, Abe JI, Takeishi Y, Konta T, Kubota I, Watanabe M. Sci Rep; 2020 Jun 25; 10(1):10345. PubMed ID: 32587339 [Abstract] [Full Text] [Related]
29. Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells. Dong F, Zhang J, Zhu S, Lan T, Yang J, Li L. J Cardiovasc Pharmacol; 2019 Nov 25; 74(5):426-435. PubMed ID: 31725079 [Abstract] [Full Text] [Related]
30. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G, Wang X, Li Y, He L. Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784 [Abstract] [Full Text] [Related]
31. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924 [Abstract] [Full Text] [Related]
33. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension. Yeo Y, Yi ES, Kim JM, Jo EK, Seo S, Kim RI, Kim KL, Sung JH, Park SG, Suh W. Hypertension; 2020 Dec 25; 76(6):1778-1786. PubMed ID: 33100045 [Abstract] [Full Text] [Related]
34. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. Nie X, Tan J, Dai Y, Liu Y, Zou J, Sun J, Ye S, Shen C, Fan L, Chen J, Bian JS. J Mol Cell Cardiol; 2018 Mar 25; 116():41-56. PubMed ID: 29374556 [Abstract] [Full Text] [Related]
36. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration. Luo S, Kan J, Zhang J, Ye P, Wang D, Jiang X, Li M, Zhu L, Gu Y. J Cardiovasc Pharmacol; 2021 Aug 01; 78(2):253-262. PubMed ID: 34554677 [Abstract] [Full Text] [Related]